Next Article in Journal
Improving Pharmacists’ Awareness of Inadequate Antibiotic Use for URTIs through an Educational Intervention: A Pilot Study
Previous Article in Journal
An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Healthcare
Volume 10
Issue 8
10.3390/healthcare10081384
healthcare-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Association of White Blood Cell Subtypes and Derived Ratios with a Mortality Outcome in Adult Patients with Polytrauma

by
Cheng-Shyuan Rau
1,†,
Shao-Chun Wu
2,†,
Ching-Hua Tsai
3,
Sheng-En Chou
3,
Wei-Ti Su
3,
Shiun-Yuan Hsu
3 and
Ching-Hua Hsieh
3,*
1
Department of Plastic Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan
2
Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan
3
Department of Trauma Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Healthcare 2022, 10(8), 1384; https://doi.org/10.3390/healthcare10081384
Submission received: 6 July 2022 / Revised: 20 July 2022 / Accepted: 21 July 2022 / Published: 25 July 2022
Browse Figure
Versions Notes

Abstract

:
Background. After trauma, the subtypes of white blood cells (WBCs) in circulation and the derived neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) may undergo relative changes and reflect the patients’ immune-inflammatory status and outcome. This retrospective study was designed to investigate the relationship between these variables and the mortality outcomes in adult patients with polytrauma, which is defined as an abbreviated injury scale (AIS) score ≥ 3 in two or more different body regions. Methods. A comparison of the expression of subtypes of WBCs, NLR, MLR, and PLR upon arrival to the emergency department was performed in selected propensity score-matched patient cohorts created from 479 adult patients with polytrauma between 1 January 2015 and 31 December 2019. A multivariate logistic regression analysis was used to identify the independent risk factors for mortality. Results. There were no significant differences in monocyte, neutrophil, and platelet counts, as well as in MLR, NLR, and PLR, between deceased (n = 118) and surviving (n = 361) patients. In the propensity score-matched patient cohorts, which showed no significant differences in sex, age, comorbidities, and injury severity, deceased patients had significantly higher lymphocyte counts than survivors (2214 ± 1372 vs. 1807 ± 1162 [106/L], respectively, p = 0.036). In addition, the multivariate logistic regression analysis revealed that the lymphocyte count (OR, 1.0; 95% confidence interval [CI], 1.00–1.06; p = 0.043) was a significant independent risk factor for mortality in these patients. Conclusions. This study revealed that there was no significant difference in the counts of monocytes, neutrophils, and platelets, as well as in MLR, NLR, and PLR, between deceased and surviving patients with polytrauma. However, a significantly higher lymphocyte count may be associated with a worse mortality.

1. Introduction

Polytrauma is a specific category of trauma wherein patients who have multiple injuries in the body have a life-threatening condition that is associated with potentially compromised physiology and dysfunction of uninjured organs [1]. The abbreviated injury scale (AIS), which scores and classifies injury according to six levels of severity, namely, (1) minor, (2) mild, (3) serious, (4) severe, (5) critical, and (6) mortal [2], has been used as the most relevant scale to indicate injury severity in different body regions. In addition, the injury severity score (ISS) describes injury severity through the sum of the squares of AIS of the three most severe injuries [3]. Although some data exist, the polytrauma proposed by Butcher et al., defined as an injury with AIS ≥ 3 points in at least two different body regions, has been widely used [4]. This definition includes the greatest percentage of the worst outcomes and a significantly larger percent of the clinically diagnosed polytrauma patients than those diagnosed according to the definition solely using the ISS. With a higher riskof mortality, more frequent intensive care unit (ICU) admissions, and longer stays in the hospital and ICU, AIS ≥ 3 for at least two body regions of a patient represents a better definition for polytrauma when compared with other definitions, i.e., ISS > 15, >16, or >17 [4,5,6].
When treating critically injured patients, it is important to identify those who are at high risk of mortality. The major determinants of outcome are expected to be the intensity of trauma injury to the subject and the immunoinflammatory response of the host [7,8]. Systemic immunoinflammatory response following severe injury may lead to immunological disturbances and increase the risk of sepsis and mortality. For those with polytrauma, such a systemic immunoinflammatory response may be exaggerated under such a high magnitude of injury. In trauma patients, some readily available parameters originating from a routine complete blood count, including red blood cells, white blood cells (WBCs), platelets, and information on subtypes of WBCs, as well as the derived neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR), have been investigated as potential biomarkers, with mixed results. The subtypes of WBCs may undergo relative changes under stress or systemic inflammation; thus, the derived ratios may also reflect the patients’ immune-inflammatory status and indicate their outcomes [9,10]. NLR, MLR, and PLR have been widely investigated as new inflammatory markers in many inflammatory, cardiovascular, and malignant diseases [11,12,13,14,15,16,17,18,19,20], and have been thought to be simple, inexpensive, and easily assessed predictors.
Under the hypothesis that the patients’ subtypes of WBCs and the levels of derived ratios of NLR, MLR, and PLR may reflect the host immune-inflammatory response following major trauma, and therefore be associated with the mortality outcomes of the patients, this study aimed to investigate whether these variables found in adult polytrauma patients upon arrival at the emergency room are associated with the mortality outcomes of these patients.

2. Materials and Methods

2.1. Enrolled Study Population

This study was approved by the Institutional Review Board (IRB) of Chang Gung Memorial Hospital (approval numbers: 202100301B0 and 202100761B0). The need for informed consent was waived by IRB regulations owing to the retrospective nature of the registered data. Of the 34,216 adult trauma patients aged ≥20 years selected from 39,135 hospitalized trauma patients registered in the Trauma Registry System of the hospital between 1 January 2015 and 31 December 2019 [21,22,23], 633 with AIS ≥ 3 in two or more different body regions were considered to have polytrauma (Figure 1). The exclusion criteria included those patients with burns (n = 1) and those with incomplete data on the WBC subpopulations and platelets (n = 153). Finally, 479 patients were included in the study.

2.2. Collection of Medical Data

Medical data were extracted from the registered data from the trauma registry system, including information on sex; age; count of monocyte, neutrophil, lymphocyte, and platelets; pre-existing comorbidities (cerebrovascular accident, hypertension (HTN), coronary artery disease, congestive heart failure, diabetes mellitus, and end-stage renal disease); Glasgow Coma Scale (GCS); and ISS. The laboratory data of the subtypes of WBCs and platelets in patients upon arrival at the emergency room were collected, and the derived MLR, NLR, and PLR were calculated by dividing the monocyte count, neutrophil count, and platelet count by the lymphocyte count, seperately, with those cell counts expressing a concentration of 106/L. The primary outcome of this study was the in-hospital mortality rate.

2.3. Statistical Analyses

All statistical analyses were performed using IBM SPSS Statistics for Windows (version 23.0; IBM Corp., Armonk, NY, USA). Two-sided Fisher exact or Pearson chi-square tests were used to compare the categorical data by calculating the odds ratio (OR) and 95% confidence interval (CI). Levene’s test was used to assess the homogeneity of variance in the continuous variables. Normally distributed continuous data were analyzed using unpaired Student’s t-test and are presented as mean ± standard deviation. Non-normally distributed data, such as GCS and ISS, were analyzed using the Mann–Whitney U-test and are presented as the median and interquartile range (IQR, Q1–Q3). To minimize the confounding effects of the baseline covariates that may be related to the assessment of MLR, NLR, PLR, and WBC subpopulations, propensity scores were estimated using multiple logistic regression analysis with adjustments for patient sex, age, pre-existing comorbidities, and ISS, and a 1:1 matched study group was created using the greedy method and a 0.2 caliper width using NCSS software (NCSS 10; NCSS Statistical software, Kaysville, UT, USA). Univariate predictive variables that resulted in patient mortality were identified, and multivariate logistic regression analysis was used to identify independent risk factors for mortality. Statistical significance was set at p < 0.05.

3. Results

3.1. Patient and Injury Characteristics of Deceased and Surviving Patients with Polytrauma

Of the 479 patients with polytrauma, 118 died and 361 survived (Table 1). There was no significant difference in sex, age, or prevalence for pre-existing comorbidities, except for a significantly lower rate of hypertension in patients who died compared with those who survived (19.5% vs. 30.7%, p = 0.018). Compared with those survival patients, the deceased patients had a significant higher rate of sustaining injuries to the head/neck (83.1% vs. 70.4%, p = 0.007) and thorax region (78.0% vs. 66.5%, p = 0.019), but a lower rate of injury to the extremities (38.1% vs. 50.7%, p = 0.018). A significantly lower GCS score (median [IQR, Q1–Q3]: 3 [3–8] vs. 13 [7–15], respectively; p < 0.001) but higher ISS (36 [28–41] vs. 27 [22–34], respectively; p < 0.001) were found in patients who died compared with in those who survived. Stratification of ISS revealed that, among the deceased patients, fewer patients had an ISS of 16–24 and more patients had an ISS of ≥25 compared with the surviving patients. There was no significant difference in the counts of monocytes, neutrophils, platelets, and lymphocytes, as well as in MLR, NLR, and PLR, between the deceased and surviving patient groups.

3.2. Comparison in the Propensity Score-Matched Patient Cohorts

A comparison was performed in 88 well-balanced pairs of propensity-score-matched patient cohorts (Table 2). In these propensity score-matched patients, there were no significant differences in sex, age, comorbidities, and ISS. The comparison in these propensity score-matched patient cohorts revealed that there was no significant difference in the counts of monocytes, neutrophils, and platelets, as well as in MLR, NLR, and PLR, between the deceased and surviving patients. However, deceased patients had a significantly higher lymphocyte count than survivors (2214 ± 1372 vs.1807 ± 1162 [106/L], respectively, p = 0.036).

3.3. Analysis of Risk Factors for Mortality

The univariate analysis revealed that the HTN, GCS score, and ISS were significant risk factors for mortality in adult patients with polytrauma (Table 3). The subsequent multivariate logistic regression analysis revealed that age (OR, 1.0; 95% CI, 1.01–1.05; p < 0.001), HTN (OR, 0.5; 95% CI, 0.26–0.98; p = 0.042), GCS (OR, 0.8; 95% CI, 0.76–0.86; p < 0.001), ISS (OR, 1.1; 95% CI, 1.07–1.14; p < 0.001), and lymphocyte count (OR, 1.0; 95% CI, 1.00–1.06; p = 0.043) were significant independent risk factors for mortality in these patients.

4. Discussion

Among the subtypes of WBCs, neutrophils are the most abundant and act as the key cell type of the innate immune system, as the first cellular line of the defense system. Monocytes are essential components of the innate immune system and act with antigen presentation to affect the adaptive immune system. In addition, lymphocytes are involved in adaptive immune responses. Trauma is expected to affect the immune defense mechanism, and it may not be surprising to find that the circulating subtypes of WBCs would not only respond to pathogenic organisms in sepsis patients, but also to the stress associated with severe trauma. Severe trauma has been reported to result in the systemic release of pro-inflammatory cytokines and inflammatory mediators into circulation with profound acute-phase responses [24,25]. The activation of neutrophils with an intensified acute inflammatory response induces hyperinflammatory responses and tissue damage, with an increased production of tumor necrosis factor-α, interleukin (IL)-1, and IL-6, as well as an uncontrolled burst of polymorphonuclear cells and macrophages [26,27,28]. Monocytes can differentiate into activated macrophages, regulate inflammatory responses through IL-10 and transforming growth factor-β1 production, and promote tissue repair [29]. Under severe trauma, the deactivation of monocytes is correlated with the injury severity of the patients [30], leading to immunocompetence of the cells with a profound loss of antigen-presenting ability [31]. However, although MLR, NLR, and PLR have been implicated as useful biomarkers for trauma patients in some studies [32,33,34,35], this study of propensity score-matched patient populations with polytrauma revealed that there was no significant difference in the counts of monocytes, neutrophils, and platelets, as well as in MLR, NLR, and PLR between patients who died and survived. In contrast, patients who died had a significantly higher lymphocyte count than the survivors. Furthermore, the multivariate analysis also revealed that the lymphocyte count was a significant independent risk factor for mortality in patients with polytrauma. In our prior study of trauma patients in the ICU, we demonstrated that a higher lymphocyte count, lower platelet count, and lower PLR were associated with a higher risk of death in ICU trauma patients [32]. We believe that, unlike some studies [28,29,30,31], MLR, NLR, and PLR failed to be associated with the mortality outcome, probably because they were assessed in more severely injured subjects, i.e., polytrauma patients. In the case of profound injury, the difference in the ratio between deceased and surviving patients could be reduced and less remarkable. The study population may determine the usefulness of the ratio of WBC subtypes applied in the clinical setting.
In this study, the deceased patients of the matched cohorts had a significantly higher lymphocyte count than the surviving patients (2214 ± 1372 vs.1807 ± 1162 [106/L], respectively, p = 0.036). Univariate and multivariate analyses showed that the lymphocyte count (OR, 1.0; 95% CI, 1.00–1.06; p = 0.043) was a significant independent risk factor for mortality, although the odds of difference was quite minimal. These results are in accordance with those reported by Riché et al. [36] in a prospective, single-center, observational study of 130 patients, in which the neutrophil count upon admission was similar between survivors and non-survivors, while the lymphocyte count was higher in non-survivors. However, the results seem to contradict those reports that lymphopenia was observed within 24 h of injury [37], persistent in those who developed multiple organ dysfunction [37], and was associated with increased mortality [38,39]. In a 2-week longitudinal study characterizing lymphocyte response patterns following severe trauma, there was dramatic activation of the circulating lymphocytes, which are generally independent of the clinical course [40]. It was reported that, after severe trauma, ISS had a negative correlation with a population of CD3(+) T cells [41]. T lymphocytes were activated following trauma, with a subsequent significant reduction in the percentage and absolute number of lymphocytes in comparison with the control [40]. In a study of 105 trauma patients with an ISS of 20 or greater, significant lymphopenia occurred in the first post-injury week, with a maximal reduction at 3 days [39]. There is an estimated 45% mortality rate in patients with a lymphocyte count of ≤500 × 106/L at 48 h [37]. Regarding the lymphocyte count and mortality outcome, we believe that, in this study, the detection of the blood profile immediately following trauma, but not days later, as in other studies, and the high injury severity of the study population may account for the difference in the observed outcome between the present study and some of the other studies. Therefore, monitoring the dynamic changes in immune cells after polytrauma may be necessary to collect more information, which is one important limitation when interpreting the results of this study.
This study also had other limitations. First, selection bias may exist owing to the retrospective study design and after excluding incomplete data. For example, the trauma database did not record patients who were declared dead on arrival at the emergency room, and only in-hospital mortality was assessed; therefore, selection bias may have existed during data analysis. Second, the platelet and WBC subtypes may interfere with resuscitation procedures, such as blood transfusion or fluid challenge, leading to a bias in the outcome measurement. Third, invasive procedures and surgery could have led to different patient outcomes; however, we can only assume that the management had uniform outcomes across the studied patients. Furthermore, this study cannot account for the characteristics and mechanisms underlying the changes in lymphocytes. Finally, the population in this study was limited to a single urban trauma center, and the results may not be generalizable to other regions.

5. Conclusions

This study revealed that a significantly higher lymphocyte count in adult patients with polytrauma upon arrival at the emergency room was associated with worse mortality outcomes. However, there was no significant difference in the counts of the monocytes, neutrophils, and platelets, as well as in MLR, NLR, and PLR between deceased and surviving patients.

Author Contributions

Conceptualization, C.-H.H.; methodology, C.-H.T., S.-E.C. and W.-T.S.; validation, C.-H.T., S.-E.C. and W.-T.S.; formal analysis, S.-Y.H.; writing—original draft preparation, C.-S.R.; writing—review and editing, S.-C.W.; supervision, C.-H.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Chang Gung Memorial Hospital, grant number CMRPG8K0362.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and was approved by the Institutional Review Board of Chang Gung Memorial Hospital (protocol code 202100301B0, 202100761B0 and date of approval 29 March 2021, 31 May 2021).

Informed Consent Statement

Not applicable.

Acknowledgments

We appreciate assistance of the Biostatistics Center, Kaohsiung Chang Gung Memorial Hospital, in the statistical analyses.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Pape, H.C.; Lefering, R.; Butcher, N.; Peitzman, A.; Leenen, L.; Marzi, I.; Lichte, P.; Josten, C.; Bouillon, B.; Schmucker, U.; et al. The definition of polytrauma revisited: An international consensus process and proposal of the new ‘Berlin definition’. J. Trauma Acute Care Surg. 2014, 77, 780–786. [Google Scholar] [CrossRef]
  2. National Library of Medicine. Rating the severity of tissue damage. I. The abbreviated scale. JAMA J. Am. Med. Assoc. 1971, 215, 277–280. [Google Scholar] [CrossRef]
  3. Baker, S.P.; O’Neill, B.; Haddon, W., Jr.; Long, W.B. The injury severity score: A method for describing patients with multiple injuries and evaluating emergency care. J. Trauma 1974, 14, 187–196. [Google Scholar] [CrossRef]
  4. Butcher, N.; Balogh, Z.J. AIS>2 in at least two body regions: A potential new anatomical definition of polytrauma. Injury 2012, 43, 196–199. [Google Scholar] [CrossRef]
  5. Butcher, N.E.; D’Este, C.; Balogh, Z.J. The quest for a universal definition of polytrauma: A trauma registry-based validation study. J. Trauma Acute Care Surg. 2014, 77, 620–623. [Google Scholar] [CrossRef]
  6. Schröter, C.; Urbanek, F.; Frömke, C.; Winkelmann, M.; Mommsen, P.; Krettek, C.; Zeckey, C. Injury severity in polytrauma patients is underestimated using the injury severity score: A single-center correlation study in air rescue. Eur. J. Trauma Emerg. Surg. 2019, 45, 83–89. [Google Scholar] [CrossRef]
  7. Surbatovic, M.; Veljovic, M.; Jevdjic, J.; Popovic, N.; Djordjevic, D.; Radakovic, S. Immunoinflammatory response in critically ill patients: Severe sepsis and/or trauma. Mediat. Inflamm. 2013, 2013, 362793. [Google Scholar] [CrossRef]
  8. Djordjevic, D.; Pejovic, J.; Surbatovic, M.; Jevdjic, J.; Radakovic, S.; Veljovic, M.; Peric, A.; Andjelic, T.; Popovic, N. Prognostic Value and Daily Trend of Interleukin-6, Neutrophil CD64 Expression, C-Reactive Protein and Lipopolysaccharide-Binding Protein in Critically Ill Patients: Reliable Predictors of Outcome or Not? J. Med. Biochem. 2015, 34, 431–439. [Google Scholar] [CrossRef] [Green Version]
  9. Liu, Y.; Du, X.; Chen, J.; Jin, Y.; Peng, L.; Wang, H.H.X.; Luo, M.; Chen, L.; Zhao, Y. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J. Infect. 2020, 81, e6–e12. [Google Scholar] [CrossRef]
  10. Belice, T.; Demir, I.; Yüksel, A. Role of neutrophil-lymphocyte-ratio in the mortality of males diagnosed with COVID-19. Iran. J. Microbiol. 2020, 12, 194–197. [Google Scholar] [CrossRef]
  11. Yapar, A.; Tokgöz, M.A.; Yapar, D.; Atalay, İ.B.; Ulucaköy, C.; Güngör, B. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma. Jt. Dis. Relat. Surg. 2021, 32, 489–496. [Google Scholar] [CrossRef]
  12. Li, Y.X.; Chang, J.Y.; He, M.Y.; Wang, H.R.; Luo, D.Q.; Li, F.H.; Li, J.H.; Ran, L. Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer. J. Oncol. 2021, 2021, 2939162. [Google Scholar] [CrossRef]
  13. Fusar-Poli, L.; Natale, A.; Amerio, A.; Cimpoesu, P.; Grimaldi Filioli, P.; Aguglia, E.; Amore, M.; Serafini, G.; Aguglia, A. Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte and Monocyte-to-Lymphocyte Ratio in Bipolar Disorder. Brain Sci. 2021, 11, 58. [Google Scholar] [CrossRef]
  14. Liu, P.; Li, P.; Peng, Z.; Xiang, Y.; Xia, C.; Wu, J.; Yang, B.; He, Z. Predictive value of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-neutrophil ratio, and neutrophil-to-monocyte ratio in lupus nephritis. Lupus 2020, 29, 1031–1039. [Google Scholar] [CrossRef]
  15. Song, H.; Jeong, M.J.; Cha, J.; Lee, J.S.; Yoo, J.G.; Song, M.J.; Kim, J.H.; Lee, S.J.; Lee, H.N.; Yoon, J.H.; et al. Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer. Int. J. Med. Sci. 2021, 18, 3712–3717. [Google Scholar] [CrossRef]
  16. Urbanowicz, T.; Olasińska-Wiśniewska, A.; Michalak, M.; Rodzki, M.; Witkowska, A.; Straburzyńska-Migaj, E.; Perek, B.; Jemielity, M. The Prognostic Significance of Neutrophil to Lymphocyte Ratio (NLR), Monocyte to Lymphocyte Ratio (MLR) and Platelet to Lymphocyte Ratio (PLR) on Long-Term Survival in Off-Pump Coronary Artery Bypass Grafting (OPCAB) Procedures. Biology 2021, 11, 34. [Google Scholar] [CrossRef]
  17. Song, S.; Bai, M.; Li, X.; Gong, S.; Yang, W.; Lei, C.; Tian, H.; Si, M.; Hao, X.; Guo, T. Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma. Expert Rev. Mol. Diagn. 2022, 22, 361–378. [Google Scholar] [CrossRef]
  18. Cheng, Y.; Wang, Y.; Wang, X.; Jiang, Z.; Zhu, L.; Fang, S. Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Monocyte-to-Lymphocyte Ratio in Depression: An Updated Systematic Review and Meta-Analysis. Front. Psychiatry 2022, 13, 893097. [Google Scholar] [CrossRef]
  19. Leng, J.; Wu, F.; Zhang, L. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis. Front. Oncol. 2022, 12, 734948. [Google Scholar] [CrossRef]
  20. Schiefer, S.; Wirsik, N.M.; Kalkum, E.; Seide, S.E.; Nienhüser, H.; Müller, B.; Billeter, A.; Büchler, M.W.; Schmidt, T.; Probst, P. Systematic Review of Prognostic Role of Blood Cell Ratios in Patients with Gastric Cancer Undergoing Surgery. Diagnostics 2022, 12, 593. [Google Scholar] [CrossRef]
  21. Hsieh, C.H.; Hsu, S.Y.; Hsieh, H.Y.; Chen, Y.C. Differences between the sexes in motorcycle-related injuries and fatalities at a Taiwanese level I trauma center. Biomed. J. 2017, 40, 113–120. [Google Scholar] [CrossRef] [PubMed]
  22. Hsieh, C.H.; Liu, H.T.; Hsu, S.Y.; Hsieh, H.Y.; Chen, Y.C. Motorcycle-related hospitalizations of the elderly. Biomed. J. 2017, 40, 121–128. [Google Scholar] [CrossRef] [PubMed]
  23. Hsieh, C.H.; Chen, Y.C.; Hsu, S.Y.; Hsieh, H.Y.; Chien, P.C. Defining polytrauma by abbreviated injury scale ≥ 3 for a least two body regions is insufficient in terms of short-term outcome: A cross-sectional study at a level I trauma center. Biomed. J. 2018, 41, 321–327. [Google Scholar] [CrossRef] [PubMed]
  24. West, S.D.; Goldberg, D.; Ziegler, A.; Krencicki, M.; Du Clos, T.W.; Mold, C. Transforming growth factor-β, macrophage colony-stimulating factor and C-reactive protein levels correlate with CD14(high)CD16+ monocyte induction and activation in trauma patients. PLoS ONE 2012, 7, e52406. [Google Scholar] [CrossRef]
  25. Wu, S.C.; Rau, C.S.; Kuo, P.J.; Shih, F.Y.; Lin, H.P.; Wu, Y.C.; Hsieh, T.M.; Liu, H.T.; Hsieh, C.H. Profiling the Expression of Circulating Acute-Phase Proteins, Cytokines, and Checkpoint Proteins in Patients with Severe Trauma: A Pilot Study. J. Inflamm. Res. 2021, 14, 3739–3753. [Google Scholar] [CrossRef]
  26. Menger, M.D.; Vollmar, B. Surgical trauma: Hyperinflammation versus immunosuppression? Langenbecks Arch. Surg. 2004, 389, 475–484. [Google Scholar] [CrossRef]
  27. Hemmat, N.; Derakhshani, A.; Bannazadeh Baghi, H.; Silvestris, N.; Baradaran, B.; De Summa, S. Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study. Front. Genet. 2020, 11, 641. [Google Scholar] [CrossRef]
  28. Feng, X.; Li, S.; Sun, Q.; Zhu, J.; Chen, B.; Xiong, M.; Cao, G. Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis. Front. Med. 2020, 7, 301. [Google Scholar] [CrossRef]
  29. Arango Duque, G.; Descoteaux, A. Macrophage cytokines: Involvement in immunity and infectious diseases. Front. Immunol. 2014, 5, 491. [Google Scholar] [CrossRef] [Green Version]
  30. West, S.D.; Mold, C. Monocyte deactivation correlates with injury severity score, but not with heme oxygenase-1 levels in trauma patients. J. Surg. Res. 2012, 172, 5–10. [Google Scholar] [CrossRef] [Green Version]
  31. Galbraith, N.; Walker, S.; Carter, J.; Polk, H.C., Jr. Past, Present, and Future of Augmentation of Monocyte Function in the Surgical Patient. Surg. Infect. 2016, 17, 563–569. [Google Scholar] [CrossRef] [PubMed]
  32. Ke, R.T.; Rau, C.S.; Hsieh, T.M.; Chou, S.E.; Su, W.T.; Hsu, S.Y.; Hsieh, C.H.; Liu, H.T. Association of Platelets and White Blood Cells Subtypes with Trauma Patients’ Mortality Outcome in the Intensive Care Unit. Healthcare 2021, 9, 942. [Google Scholar] [CrossRef] [PubMed]
  33. Sabouri, E.; Majdi, A.; Jangjui, P.; Rahigh Aghsan, S.; Naseri Alavi, S.A. Neutrophil-to-Lymphocyte Ratio and Traumatic Brain Injury: A Review Study. World Neurosurg. 2020, 140, 142–147. [Google Scholar] [CrossRef] [PubMed]
  34. El-Menyar, A.; Mekkodathil, A.; Al-Ansari, A.; Asim, M.; Elmenyar, E.; Rizoli, S.; Al-Thani, H. Platelet-Lymphocyte and Neutrophil-Lymphocyte Ratio for Prediction of Hospital Outcomes in Patients with Abdominal Trauma. Biomed. Res. Int. 2022, 2022, 5374419. [Google Scholar] [CrossRef] [PubMed]
  35. Jo, S.; Jeong, T.; Lee, J.B.; Jin, Y.; Yoon, J.; Park, B. The prognostic value of platelet-to-lymphocyte ratio on in-hospital mortality in admitted adult traffic accident patients. PLoS ONE 2020, 15, e0233838. [Google Scholar] [CrossRef] [PubMed]
  36. Riché, F.; Gayat, E.; Barthélémy, R.; Le Dorze, M.; Matéo, J.; Payen, D. Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit. Care 2015, 19, 439. [Google Scholar] [CrossRef] [Green Version]
  37. Manson, J.; Cole, E.; De’Ath, H.D.; Vulliamy, P.; Meier, U.; Pennington, D.; Brohi, K. Early changes within the lymphocyte population are associated with the development of multiple organ dysfunction syndrome in trauma patients. Crit. Care 2016, 20, 176. [Google Scholar] [CrossRef] [Green Version]
  38. Heffernan, D.S.; Monaghan, S.F.; Thakkar, R.K.; Machan, J.T.; Cioffi, W.G.; Ayala, A. Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern. Crit. Care 2012, 16, R12. [Google Scholar] [CrossRef] [Green Version]
  39. Cheadle, W.G.; Pemberton, R.M.; Robinson, D.; Livingston, D.H.; Rodriguez, J.L.; Polk, H.C., Jr. Lymphocyte subset responses to trauma and sepsis. J. Trauma 1993, 35, 844–849. [Google Scholar] [CrossRef]
  40. Walsh, D.S.; Siritongtaworn, P.; Pattanapanyasat, K.; Thavichaigarn, P.; Kongcharoen, P.; Jiarakul, N.; Tongtawe, P.; Yongvanitchit, K.; Komoltri, C.; Dheeradhada, C.; et al. Lymphocyte activation after non-thermal trauma. Br. J. Surg. 2000, 87, 223–230. [Google Scholar] [CrossRef]
  41. Hua, R.; Chen, F.X.; Zhang, Y.M.; Zhou, Z.H.; Wang, S.J.; Liang, J. Association of traumatic severity with change in lymphocyte subsets in the early stage after trauma. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2013, 25, 489–492. [Google Scholar] [CrossRef] [PubMed]
Healthcare 10 01384 g001 550
Figure 1. Flowchart of the process for enrolling adult patients with polytrauma.
Figure 1. Flowchart of the process for enrolling adult patients with polytrauma.
Healthcare 10 01384 g001
Table
Table 1. Patient and injury characteristics of the deceased and surviving patients with polytrauma.
Table 1. Patient and injury characteristics of the deceased and surviving patients with polytrauma.
VariablesDeath n = 118Survival n = 361OR (95% CI)p
Male, n (%)87(73.7)234(64.8)1.5 (0.96–2.42)0.074
Age, age55.0±20.756.5±20.2-0.487
Comorbidities
 CVA, n (%)1(0.8)10(2.8)0.3 (0.04–2.37)0.226
 HTN, n (%)23(19.5)111(30.7)0.5 (0.33–0.91)0.018
 CAD, n (%)6(5.1)18(5.0)1.0 (0.40–2.64)0.966
 CHF, n (%)0(0.0)1(0.3)-0.567
 DM, n (%)14(11.9)61(16.9)0.7 (0.36–1.23)0.192
 ESRD, n (%)0(0.0)6(1.7)-0.159
GCS, median (IQR)3(3–8)13(7–15)-<0.001
Injured region, AIS ≥ 3
 Head/Neck, n(%)98(83.1)254(70.4)2.1 (1.21–3.51)0.007
 Face, n (%)5(4.2)9(2.5)1.7 (0.57–5.27)0.329
 Thorax, n (%)92(78.0)240(66.5)1. 8 (1.10–2.90)0.019
 Abdomen, n (%)26(22.0)88(24.4)0.9 (0.53–1.44)0.604
 Extremity, n (%)45(38.1)183(50.7)0.6 (0.39–0.92)0.018
 External, n (%)0(0.0)1(0.3)-0.567
ISS, median (IQR)36(29–41)27(22–34)-<0.001
 16–244(3.4)110(30.5)0.1 (0.03–0.22)<0.001
 ≥25114(96.6)251(69.5)12.5 (4.50–34.70)<0.001
Monocytes (106/L)556±361576±358-0.599
Neutrophils (106/L)8899±60209331±5019-0.441
Platelets (106/L)232,805±75,994221,967±68,481-0.147
Lymphocytes (106/L)2130±13111996±1534-0.394
MLR0.4±0.40.4±0.3-0.746
NLR6.9±10.46.7±5.6-0.829
PLR149.4±100.8146.2±80.1-0.728
CAD = coronary artery disease; CHF = congestive heart failure; CI = confidence interval; CVA = cerebral vascular accident; DM = diabetes mellitus; ESRD = end-stage renal disease; GCS = Glasgow Coma Scale; HTN = hypertension; IQR = interquartile range; ISS = injury severity score; MLR = monocyte-to-lymphocyte ratio; NLR = neutrophil-to-lymphocyte ratio; OR= odds ratio; PLR = platelet-to-lymphocyte ratio.
Table
Table 2. Comparison of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and subtypes of white blood cells in propensity score-matched cohorts of patients with polytrauma.
Table 2. Comparison of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and subtypes of white blood cells in propensity score-matched cohorts of patients with polytrauma.
VariablesPropensity Score-Matched Patient Cohorts
Death n = 88Survival n = 88OR (95% CI)pSD
Male, n (%)69(78.4)69(78.4)1.0 (0.49–2.05)1.0000.00%
Age, age53.5±20.852.5±18.2-0.7345.12%
Comorbidities
 CVA, n (%)0(0.0)0(0.0)---
 HTN, n (%)9(10.2)9(1.2)1.0 (0.38–2.65)1.0000.00%
 CAD, n (%)1(1.1)1(1.1)1.0 (0.06–16.24)1.0000.00%
 CHF, n (%)0(0.0)0(0.0)---
 DM, n (%)9(10.2)9(10.2)1.0 (0.38–2.65)1.0000.00%
 ESRD, n (%)0(0.0)0(0.0)---
 GCS, n (%)6.5±4.57.02±4.1-0.382−13.22%
ISS34.6±7.134.4±7.7-0.8632.60%
Monocytes (106/L)594±385580±361-0.805-
Neutrophils (106/L)9316±65079930±5415-0.497-
Platelets (106/L)238,284±78,318231,761±75,263-0.574-
Lymphocytes (106/L)2214±13721807±1162-0.036-
MLR0.2±0.50.3±0.5-0.762-
NLR6.4±7.17.5±6.3-0.261-
PLR145.8±100.2157.6±75.8-0.378-
CAD = coronary artery disease; CHF = congestive heart failure; CI = confidence interval; CVA = cerebral vascular accident; DM = diabetes mellitus; ESRD = end-stage renal disease; GCS = Glasgow Coma Scale; HTN = hypertension; ISS = injury severity score; MLR = monocyte to lymphocyte ratio; NLR = neutrophil to lymphocyte ratio; OR= odds ratio; PLR = platelet-to-lymphocyte ratio; SD = Standardized Difference between matched cohorts.
Table
Table 3. Results of the univariate and multivariate analyses to identify independent risk factors for mortality in patients with polytrauma.
Table 3. Results of the univariate and multivariate analyses to identify independent risk factors for mortality in patients with polytrauma.
VariablesUnivariate AnalysisMultivariable Analysis
OR95% CIpOR95% CIp
Age1.0(0.99–1.01)0.4861.0(1.01–1.05)<0.001
Male1.5(0.96–2.42)0.0751.1(0.62–1.99)0.721
HTN1.8(1.10–3.05)0.0190.5(0.26–0.98)0.042
GCS0.8(0.75–0.84)<0.0010.8(0.76–0.86)<0.001
ISS1.1(1.09–1.16)<0.0011.1(1.07–1.14)<0.001
Monocytes1.0(0.93–1.05)0.5981.0(0.84–1.16)0.880
Neutrophils1.0(0.99–1.00)0.4411.0(0.99–1.01)0.556
Platelets1.0(0.99–1.05)0.1481.0(0.97–1.07)0.512
Lymphocytes1.0(0.99–1.04)0.0991.0(1.00–1.06)0.043
MLR0.9(0.49–1.68)0.7450.9(0.10–7.43)0.883
NLR1.0(0.98–1.03)0.7721.0(0.94–1.11)0.599
PLR1.0(0.98–1.03)0.7281.0(0.95–1.06)0.948
CI = confidence interval; GCS = Glasgow Coma Scale; HTN = hypertension; ISS = injury severity score; MLR = monocyte to lymphocyte ratio; NLR = neutrophil to lymphocyte ratio; OR= odds ratio; PLR = platelet-to-lymphocyte ratio.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Rau, C.-S.; Wu, S.-C.; Tsai, C.-H.; Chou, S.-E.; Su, W.-T.; Hsu, S.-Y.; Hsieh, C.-H. Association of White Blood Cell Subtypes and Derived Ratios with a Mortality Outcome in Adult Patients with Polytrauma. Healthcare 2022, 10, 1384. https://doi.org/10.3390/healthcare10081384

AMA Style

Rau C-S, Wu S-C, Tsai C-H, Chou S-E, Su W-T, Hsu S-Y, Hsieh C-H. Association of White Blood Cell Subtypes and Derived Ratios with a Mortality Outcome in Adult Patients with Polytrauma. Healthcare. 2022; 10(8):1384. https://doi.org/10.3390/healthcare10081384

Chicago/Turabian Style

Rau, Cheng-Shyuan, Shao-Chun Wu, Ching-Hua Tsai, Sheng-En Chou, Wei-Ti Su, Shiun-Yuan Hsu, and Ching-Hua Hsieh. 2022. "Association of White Blood Cell Subtypes and Derived Ratios with a Mortality Outcome in Adult Patients with Polytrauma" Healthcare 10, no. 8: 1384. https://doi.org/10.3390/healthcare10081384

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop